
Publicação: 24 de abril de 2019
In Brazil, we are facing an alarming epidemic scenario of Yellow fever (YF), which is reaching the most populous areas of the country in unvaccinated people. Vaccination is the only effective tool to prevent YF. In special situations, such as patients with chronic immune-mediated inflammatory diseases (CIMID), undergoing immunosuppressive therapy, as a higher risk of severe adverse events may occur, assessment of the risk-benefit ratio of the yellow fever vaccine (YFV) should be performed on an individual level.
Dr. Marcus Lacerda, um dos coautores, participou como SBMT quando foi presidente!
In Brazil, we are facing an alarming epidemic scenario of Yellow fever (YF), which is reaching the most populous areas of the country in unvaccinated people. Vaccination is the only effective tool to prevent YF. In special situations, such as patients with chronic immune-mediated inflammatory diseases (CIMID), undergoing immunosuppressive therapy, as a higher risk of severe adverse events may occur, assessment of the risk-benefit ratio of the yellow fever vaccine (YFV) should be performed on an individual level.
Acesse: https://advancesinrheumatology.biomedcentral.com/articles/10.1186/s42358-019-0056-x…
Este ano, o prêmio contempla trabalhos realizados por universitários de cursos de Comunicação. Inscrições seguem até o dia 25 de outubro
Dois novos casos de infecção pelo vírus sabiá (SABV) foram identificados usando metagenômica em pacientes com suspeita de febre amarela grave
O Kit NAT Chagas reúne todos os compostos necessários para a identificação do DNA do Trypanosoma cruzi
.